Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated According to Uridine Diphosphate Glucuronosyltransferase 1A1 Genotyping in Patients With Metastatic Colorectal Cancer

We analyzed the results of previously treated patients with metastatic colorectal cancer (mCRC) who received regorafenib plus FOLFIRI with the irinotecan dose escalation on the basis of uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) genotyping. Thirteen patients with previously treated mCR...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncol Res
Main Authors: Ma, Cheng-Jen, Huang, Ching-Wen, Yeh, Yung-Sung, Tsai, Hsiang-Lin, Hu, Huang-Ming, Wu, I-Chen, Cheng, Tian-Lu, Wang, Jaw-Yuan
Format: Artigo
Jezik:Inglês
Izdano: Cognizant Communication Corporation 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7840952/
https://ncbi.nlm.nih.gov/pubmed/27938508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/97818823455816X14786040691928
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki